Filing metadata

Accession number
0001209191-22-059514
Form type
Form 4
Filer
Kinnate Biopharma Inc.
CIK
CIK 1797768
Filed
Dec 02, 2022
Reporting period
Dec 01, 2022
Description
Insider transaction

Explore SEC Filings Hub

4 | SEC Filings Hub